BRO three-lens brief
Evidence-based stock research on BRO. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 23.8pp over 30 days. · Trading at 2% of its 52-week range — deep in the lower band.
- Trading at 2% of its 52-week range — deep in the lower band.
- RSI at 30 — technically oversold.
- Underperforming SPY by 23.8pp over 30 days.
- Analyst mean target $74.93 — 28% above current (15 analysts).
- Debt-to-equity of 64.4 — balance-sheet-heavy.
BRO closed at $58.61 (+1.69%) as of 2026-05-04. Market cap: $19.86B. P/E (trailing) 19.1. Positives: analyst mean target $74.93 — 28% above current (15 analysts).. Concerns: trading at 2% of its 52-week range — deep in the lower band.; rSI at 30 — technically oversold.. Last quarter: Revenue $1.90B, net income $426.00M, free cash flow $1.52B.
Why three lenses on BRO, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BROacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BRO" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BRO brief"></iframe>